Immunogenicity : Tuned
Adendra Therapeutics is applying emerging insights into dendritic cell biology to generate new treatments for solid tumors and autoimmune diseases.
Latest News
17 January 2023
Why I invited investors into my lab: Adendra Therapeutics co-founder Caetano Reis e Sousa in conversation with The Francis Crick Institute